Citigroup Reiterates Rentokil Initial (RKLIF) Buy Recommendation

Citigroup reiterated a Buy rating on Rentokil Initial (OTCPK:RKLIF), with analysts projecting an average one-year price target of $5.77, representing a 10.14% upside from its current $5.24 closing price, alongside projected annual revenue growth of 5.20% to 5,822MM and non-GAAP EPS of $0.28. Institutional sentiment shows a 3.05% increase in total shares owned by institutions to 92.68 million, with several major funds, including Janus Henderson and Aristotle Capital Management, significantly increasing their positions and portfolio allocations in the company.

Analysis

Citigroup reiterated a "Buy" recommendation for Rentokil Initial (OTCPK:RKLIF) on October 24, 2025, with an average one-year price target of $5.77, implying a 10.14% upside from its latest reported closing price of $5.24. This positive analyst outlook is underpinned by projected annual revenue growth of 5.20% to $5,822MM and a non-GAAP EPS of $0.28.

Institutional sentiment for RKLIF remains robust, evidenced by a 3.05% increase in total shares owned by institutions, reaching 92.679 million shares over the last three months. Although the number of reporting funds decreased by 6.25% (3 owners), the average portfolio weight dedicated to RKLIF increased by 1.16%, suggesting higher conviction among the remaining institutional holders.

Several major institutional investors significantly increased their positions; for instance, Janus Henderson Enterprise Fund boosted its RKLIF holdings by 24.92% and its portfolio allocation by 31.37%. Similarly, Janus Henderson Overseas Fund increased its stake by 8.02%, while Aristotle Capital Management raised its ownership by 1.55% and portfolio allocation by 5.62%, signaling strong buy-side interest despite a minor decrease in allocation from Brown Advisory Global Leaders Fund.

Key Decisions for Investors

• Investors should consider Rentokil Initial (RKLIF) for potential long positions given the reiterated "Buy" rating, 10.14% projected upside, and positive fundamental projections.
• Monitor the quality of institutional ownership, noting the increase in total shares held and average portfolio weight, which suggests high conviction despite a slight reduction in the number of funds.
• Evaluate RKLIF's projected 5.20% revenue growth and $0.28 non-GAAP EPS in the context of its industry and competitive landscape to assess the sustainability of its valuation.